Ezgu, F. S. 2022. Safety of sebelipase alfa for the treatment of lysosomal acid lipase deficiency.. Expert opinion on drug safety , vol.21, no.2 , 149-155.

Ezgu, F. S., (2022). Safety of sebelipase alfa for the treatment of lysosomal acid lipase deficiency.. Expert opinion on drug safety , vol.21, no.2, 149-155.

Ezgu, FATİH. "Safety of sebelipase alfa for the treatment of lysosomal acid lipase deficiency.," Expert opinion on drug safety , vol.21, no.2, 149-155, 2022

Ezgu, FATİH S. . "Safety of sebelipase alfa for the treatment of lysosomal acid lipase deficiency.." Expert opinion on drug safety , vol.21, no.2, pp.149-155, 2022

Ezgu, F. S. (2022) . "Safety of sebelipase alfa for the treatment of lysosomal acid lipase deficiency.." Expert opinion on drug safety , vol.21, no.2, pp.149-155.

@article{article, author={FATİH SÜHEYL EZGÜ}, title={Safety of sebelipase alfa for the treatment of lysosomal acid lipase deficiency.}, journal={Expert opinion on drug safety}, year=2022, pages={149-155} }